These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 3861240)
1. Specific protein phosphorylation in human promyelocytic HL-60 leukemia cells susceptible or resistant to induction of cell differentiation by phorbol-12-myristate-13-acetate. Anderson NL; Gemmell MA; Coussens PM; Murao S; Huberman E Cancer Res; 1985 Oct; 45(10):4955-62. PubMed ID: 3861240 [TBL] [Abstract][Full Text] [Related]
2. Cell-free system studies on the phosphorylation of the 17,000-20,000 dalton protein induced by phorbol ester in human leukemic cells and evidence for a similar event in virally transformed murine fibroblasts. Feuerstein N; Nishikawa M; Cooper HL Cancer Res; 1985 Jul; 45(7):3243-51. PubMed ID: 3159476 [TBL] [Abstract][Full Text] [Related]
3. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856 [TBL] [Abstract][Full Text] [Related]
4. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity. Constantinou A; Henning-Chubb C; Huberman E Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141 [TBL] [Abstract][Full Text] [Related]
5. Differential phosphorylation events associated with phorbol ester effects on acceleration versus inhibition of cell growth. Feuerstein N; Sahai A; Anderson WB; Salomon DS; Cooper HL Cancer Res; 1984 Nov; 44(11):5227-33. PubMed ID: 6593117 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation. Tonetti DA; Horio M; Collart FR; Huberman E Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803 [TBL] [Abstract][Full Text] [Related]
7. Rapid increase of the human IFN-gamma receptor phosphorylation in response to human IFN-gamma and phorbol myristate acetate. Involvement of different serine/threonine kinases. Mao C; Merlin G; Ballotti R; Metzler M; Aguet M J Immunol; 1990 Dec; 145(12):4257-64. PubMed ID: 2147939 [TBL] [Abstract][Full Text] [Related]
8. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60. Zylber-Katz E; Glazer RI Cancer Res; 1985 Oct; 45(10):5159-64. PubMed ID: 3161611 [TBL] [Abstract][Full Text] [Related]
9. Changes in the patterns of protein phosphorylation associated with granulocytic and monocytic-induced differentiation of HL-60 cells. Faille A; Poirier O; Turmel P; Chomienne C; Charron DJ; Abita JP Anticancer Res; 1986; 6(5):1053-63. PubMed ID: 3467646 [TBL] [Abstract][Full Text] [Related]
10. Decreased synthesis of high-molecular-weight glycopeptides in human promyelocytic leukemic cells (HL-60) during phorbol ester-induced macrophage differentiation. Cossu G; Kuo AL; Pessano S; Warren L; Cooper RA Cancer Res; 1982 Feb; 42(2):484-9. PubMed ID: 6948606 [TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Aquino A; Hartman KD; Knode MC; Grant S; Huang KP; Niu CH; Glazer RI Cancer Res; 1988 Jun; 48(12):3324-9. PubMed ID: 3130982 [TBL] [Abstract][Full Text] [Related]
12. Double minute chromatin bodies and other chromosome alterations in human myeloid HL-60 leukemia cells susceptible or resistant to induction of differentiation by phorbol-12-myristate-13-acetate. Au WW; Callaham MF; Workman ML; Huberman E Cancer Res; 1983 Dec; 43(12 Pt 1):5873-8. PubMed ID: 6580064 [TBL] [Abstract][Full Text] [Related]
13. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155 [TBL] [Abstract][Full Text] [Related]
14. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135 [TBL] [Abstract][Full Text] [Related]
15. Rapid phosphorylation-dephosphorylation of specific proteins induced by phorbol ester in HL-60 cells. Further characterization of the phosphorylation of 17-kilodalton and 27-kilodalton proteins in myeloid leukemic cells and human monocytes. Feuerstein N; Cooper HL J Biol Chem; 1984 Mar; 259(5):2782-8. PubMed ID: 6583202 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase C activities with different characteristics, including substrate specificity, from two human HL-60 leukemia cell variants. Homma Y; Gemmell MA; Huberman E Cancer Res; 1988 May; 48(10):2744-8. PubMed ID: 3162823 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate. Gardner JP; Melnick DA; Malech HL J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells. Chung TW; Choi HJ; Lee YC; Kim CH Glycobiology; 2005 Mar; 15(3):233-44. PubMed ID: 15385432 [TBL] [Abstract][Full Text] [Related]
19. Effect of in vitro differentiation on phorbol diester receptor number in human promyelocytic leukemia (HL-60) cells. Lane RW; Sturm RJ; Borzelleca JF; Carchman RA Cancer Res; 1986 Aug; 46(8):3782-8. PubMed ID: 3460690 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by palmitoylcarnitine of adhesion and morphological changes in HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate. Nakaki T; Mita S; Yamamoto S; Nakadate T; Kato R Cancer Res; 1984 May; 44(5):1908-12. PubMed ID: 6324991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]